论文部分内容阅读
目的探讨依达拉奉治疗急性脑梗死临床效果。方法回顾分析82例患者的临床资料。结果两组治疗前后临床疗效比较见表1;两组治疗前后CSS评分比较见表2;所有患者在用药过程中检测血压变化,肝肾功能、血糖等;无明显不良反应。结论依达拉奉注射液能有效改善发病早期脑梗死患者近期的神经功能缺损,且无明显不良反应,安全有效,值得临床应用。
Objective To investigate the clinical efficacy of edaravone in the treatment of acute cerebral infarction. Methods The clinical data of 82 patients were retrospectively analyzed. Results The clinical curative effect of the two groups before and after treatment is shown in Table 1. The CSS scores of the two groups before and after treatment are shown in Table 2. All the patients tested the changes of blood pressure, liver and kidney function, blood sugar and so on during the course of medication. There was no obvious adverse reaction. Conclusion Edaravone injection can effectively improve the recent neurological deficits in patients with early onset of cerebral infarction, and no obvious adverse reactions, safe and effective, worthy of clinical application.